LAB FY 2013 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$374M

FY 2013 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$71M+36.0% YoY

Gross Profit

$51M71.8% margin

Operating Income

-$18M-25.2% margin

Net Income

-$16M-22.2% margin

EPS (Diluted)

$-0.62

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$6M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$117M

Total Liabilities

$20M

Stockholders' Equity

$97M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$52M	+36.0%
Gross Profit	$51M	$37M	+38.1%
Operating Income	-$18M	-$18M	+0.7%
Net Income	-$16M	-$19M	+16.8%